Outcomes among Hospitalized Chronic Kidney Disease Patients with COVID-19.

ABSTRACT:

Background

Patients with CKD ha ve impaired immunity, increased risk of infection-related mortality, and worsened COVID-19 outcomes. However, data comparing nondialysis CKD and ESKD are sparse.

Methods

Patients with COVID-19 admitted to three hospitals in the New York area, between March 2 and August 27, 2020, were retrospectively studied using electronic health records. Patients were classified as those without CKD, those with nondialysis CKD, and those with ESKD, with outcomes including hospital mortality, ICU admission, and mortality rates.

Results

Of 3905 patients, 588 (15%) had nondialysis CKD and 128 (3%) had ESKD. The nondialysis CKD and ESKD groups had a greater prevalence of comorbidities and higher admission D-dimer levels, whereas patients with ESKD had low

SUBMITTER: Khatri M 

PROVIDER: S-EPMC8786103 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature